Analyst Price Targets — SNY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 11:26 am | Sarita Kapila | Morgan Stanley | $49.00 | $42.98 | TheFly | Sanofi price target lowered to $49 from $52 at Morgan Stanley |
| May 1, 2026 7:34 pm | — | Morgan Stanley | $52.00 | $46.08 | TheFly | Sanofi downgraded to Equal Weight from Overweight at Morgan Stanley |
| April 20, 2026 8:31 am | Peter Verdult | BNP Paribas | $50.00 | $48.06 | TheFly | Sanofi downgraded to Neutral from Outperform at BNP Paribas |
| June 2, 2025 10:07 am | Sarita Kapila | Morgan Stanley | $56.00 | $49.19 | TheFly | Sanofi resumed with an Equal Weight at Morgan Stanley |
| September 10, 2024 5:42 am | Luisa Hector | Berenberg Bank | $64.00 | $58.51 | TheFly | Sanofi price target raised to $64 from $56 at Berenberg |
| July 26, 2024 7:33 am | Jasper Hellweg | Argus Research | $60.00 | $52.54 | StreetInsider | Sanofi-Aventis (SNY) PT Raised to $60 at Argus |
| April 3, 2024 12:55 pm | Jasper Hellweg | Argus Research | $55.00 | $48.00 | StreetInsider | Sanofi-Aventis (SNY) PT Lowered to $55 at Argus, 'BUY as FDA reviews Dupixent for COPD' |
| December 21, 2022 1:30 pm | Iain Simpson | Barclays | $48.07 | $48.17 | TheFly | Sanofi confirms to Bloomberg Zantac settlement in California |
Latest News for SNY
PARIS & LONDON--(BUSINESS WIRE)-- #DrugDiscovery--Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first…
All three can be bought on the dip.
Sanofi's subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
The U.S. Food and Drug Administration said on Friday it has approved Sanofi's blood cancer drug, Sarclisa, which can be given under the skin through a wearable injector, offering multiple myeloma patients a less burdensome alternative to intravenous infusions.
The European Commission said on Wednesday it would seek feedback on commitments offered by French pharmaceutical company Sanofi to address concerns that it may have breached competition rules in a flu vaccine marketing campaign.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SNY.
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.